National Health (Prescriber bag supplies) Amendment Determination 2018 (No. 3) (PB 53 of 2018) (Cth)

PB 53 of 2018

National Health (Prescriber bag supplies) Amendment Determination 2018 (No. 3)

National Health Act 1953

___________________________________________________________________________

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under sections 93 and 93AB of the National Health Act 1953.

Dated                  27^th June 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Determination

(1)This Determination is the National Health (Prescriber bag supplies) Amendment Determination 2018 (No. 3).

(2)This Determination may also be cited as PB 53 of 2018.

1. Commencement

This Determination commences on 1 July 2018.

1. Amendment of National Health (Prescriber bag supplies) Determination 2012

Schedule 1 amends the National Health (Prescriber bag supplies) Determination 2012 (PB 73 of 2012).

Schedule 1  Amendments

1. Schedule, entry for Arenaline

omit from the column headed “Listed Drug”:        Adrenaline                substitute:      Adrenaline (epinephrine)

1. Schedule, entry for Benztropine [Maximum Quantity: 5]

(a)omit from the column headed “Listed Drug”:        Benztropine   substitute:      Benzatropine

(b)omit from the column headed “Form”:       Injection containing benztropine mesylate 2 mg in 2 mL

substitute:   Injection containing benzatropine mesilate 2 mg in 2 mL

1. Schedule, entry for Benztropine [Maximum Quantity: 10]

(a)omit from the column headed “Listed Drug”:        Benztropine   substitute:      Benzatropine

(b)omit from the column headed “Form”:       Injection containing benztropine mesylate 2 mg in 2 mL

substitute:   Injection containing benzatropine mesilate 2 mg in 2 mL

1. Schedule, entry for Procaine Penicillin

omit from the column headed “Listed Drug”:        Procaine Penicillin   substitute:      Procaine benzylpenicillin

1. Schedule, entry for Frusemide

omit from the column headed “Listed Drug”:        Frusemide                substitute:      Furosemide

1. Schedule, entry for Lignocaine

(a)omit from the column headed “Listed Drug”:        Lignocaine               substitute:      Lidocaine

(b)omit from the column headed “Form”:       Injection containing lignocaine hydrochloride 50 mg in 5 mL

substitute:   Injection containing lidocaine hydrochloride 50 mg in 5 mL

1. Schedule, entry for Prochlorperazine

omit from the column headed “Form”:       Injection containing prochlorperazine mesylate 12.5 mg in 1 mL

substitute:            Injection containing prochlorperazine mesilate 12.5 mg in 1 mL